Aiforia
Healthcare Software · Finland · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Tukholmankatu 8, Helsinki, Uusimaa, 0029...Phone Number
+358 207349130Website
www.aiforia.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
1
1
1
1
About Aiforia
Aiforia equips pathologists and scientists in preclinical, academic, and clinical labs with the most powerful deep learning artificial intelligence and cloud-based technology to increase the speed, accuracy and consistency of analyzing large and complex medical images across a variety of fields from oncology to neuroscience. Aiforia is composed of an ideal mix of scientists experienced in a variety of medical areas from pathology to cancer diagnostics, software developers, experience in artificial intelligence, and a business team with backgrounds in the pharmaceutical and biotechnology industries. The company was founded in 2013 and is headquartered in Finland.Explore more
Aiforia Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aiforia your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Aiforia has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Aiforia has new funding data
Earning: See what the market has to say on Aiforia recently announced quarterly report
Check out if Aiforia is spiking on competitors!
Click to see if Aiforia had a recent Job posting/layoffs
Product Launch: Get notified when Aiforia launches new products
Aiforia, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Aiforia
Recommended Actions
Find VP level buyers at Aiforia
Find 2 more new buyers
Company Profile Activity
Activity Insights
Aiforia is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Aiforia is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Aiforia.
Aiforia financials insights
Gather financial insights about Aiforia, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series A
$5.3M
2021
Series B
$15.2M
Aiforia Tech Stack
A closer look at the technologies used by Aiforia
See more technologies
Most Recent Scoops
Partnership
Project
Integration, Partnership, Business Development, Software, Artificial Intelligence, Healthcare Technology, Radiology
Event
Events, Clinical Operations, Field Marketing, Healthcare Technology, Patient Experience
Event
Events, Clinical Operations, Field Marketing, Healthcare Technology, Patient Experience
Open Position
Aiforia News & Media
Orion and Aiforia extend collaboration to preclinical study evaluations
ORION CORPORATION PRESS RELEASE 5 MARCH 2025 at 9.00 EETAiforia Technologies Plc updates its short and mid-term business targets
Aiforia Technologies Oyj, Inside information, January 19, 2024 at 09:30 a.m. EET. Aiforia's Board of Directors has approved the company's revised growth strategy and updated business targets. Aiforia wants to revolutionize pathology image analysis with the power of AI to provide better care for every patient. The company's vision is to be the global leader in AI-powered pathology image analysis. Aiforia’s growth is supported by megatrends such as increasing rates of cancer and chronic diseases,Aiforia signs a licensing agreement with the Mayo Clinic for an AI model that improves prediction of colorectal cancer recurrence
Aiforia Technologies Plc, Press release, January 2, 2024 at 10.00 a.m. EET. Aiforia has entered into an exclusive licensing agreement with the Mayo Clinic in the United States to globally commercialize an AI model that improves prediction of colorectal cancer recurrence. The AI model was developed in collaboration with the Mayo Clinic. The AI model identifies important histological features of colorectal cancer and provides a recurrence prediction estimate useful for colorectal cancer treatmentAiforia signs a deal with an Italian hospital in Catania
Aiforia Technologies Plc, Press Release, December 27, 2023 at 01:00 p.m. EET. The Provincial Health Authority of Catania in Italy has selected Aiforia Technologies Plc as a partner for AI-assisted diagnostics in the anatomic pathology laboratory of Gravina Hospital. The collaboration involves the use of the Aiforia Clinical AI solutions for the analysis of tissue samples from breast and prostate cancer patients, as well as the use of the Aiforia AI model development platform. The
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aiforia
Sign Up For FreeTo access detailed company insights
Aiforia equips pathologists and scientists in preclinical, academic, and clinical labs with the most powerful deep learning artificial intelligence and cloud-based technology to increase the speed, accuracy and consistency of analyzing large and complex medical images across a variety of fields from oncology to neuroscience. Aiforia is composed of... Read More
